Document ID: ./input/supremecourt_opinions/opinions/22pdf/22a901_3d9g.pdf
Page Number: 4

4 

DANCO LABORATORIES, LLC v. ALLIANCE FOR
HIPPOCRATIC MEDICINE 
ALITO, J., dissenting 

regulations then in force prohibited, and here, the Govern-
ment has not dispelled legitimate doubts that it would even 
obey an unfavorable order in these cases, much less that it
would  choose  to  take  enforcement  actions  to  which  it  has 
strong objections.

For  these  reasons,  I  would  deny  the  stay  applications.
Contrary to the impression that may be held by many, that
disposition would not express any view on the merits of the 
question whether the FDA acted lawfully in any of its ac-
tions regarding mifepristone.  Rather, it would simply re-
fuse to take a step that has not been shown as necessary to
avoid  the  threat  of  any  real  harm  during  the  presumably 
short period at issue.